Ginekologia Polska nr 7-1

ORIGINAL PAPER / GYNECOLOGY

Validation of the Polish version of P-QoL questionnaire

Jakub Rzepka1, 2, Kamil Zalewski1, 3, Artur Stefanowicz3, Vik Khullar4, Steven Swift5,
G Alessandro Digesu4

1Department of Gynecologic Oncology, Hollycross Cancer Center, Kielce, Poland
2
Center for Postgraduate Education, Department of Obstetrics and Gynaecology, Bielanski Hospital, Warsaw, Poland
3
Chair And Department Of Obstetrics, Gynaecology and Gynaecologic Oncology, IInd Faculty of Medicine,
Warsaw Medical University, Poland
4
Department of Urogynaecology, St Mary’s Hospital, Imperial College NHS Trust, London, United Kingdom
5Department of Obstetrics and Gynecology, Medical University of South Carolina, Charleston, USA

Corresponding author:

Jakub Rzepka

Center for Postgraduate Education, Department of Obstetrics and Gynaecology, Bielanski Hospital, Warsaw, Poland

tel.: +48 510 039 600, e-mail: kuba.rzepka@gmail.com

ABSTRACT

Objective: Pelvic organ prolapse (POP) is a common morbidity that affects many women and significantly decreases quality of life. The severity and the impact of the prolapse on the quality of life are important parameters in the management and follow-up of affected patients. The aim of this validation study was to validate the Polish version of the Prolapse Quality of Life questionnaire (P-QoL).

Material and methods: The P-QOL questionnaire was translated into Polish and administered to women recruited from two gynecological outpatient clinics (n = 231). Both symptomatic and asymptomatic women were included in the study and examined in supine position using the Pelvic Organ Prolapse Quantification System (POP-Q). The validity was assessed by comparing symptom scores and quality-of-life scores between symptomatic and asymptomatic women.

Results: A total number of 154 symptomatic and 77 asymptomatic women were included. There was a strong correlation between severity of the disease based on physical findings (POP-Q scale) and the P-QoL scores in main prolapse quality-of-life domains. The overall scores for each life domain were significantly different between symptomatic and asymptomatic women (p < 0.001). All the questions regarding symptoms showed significant differences (p < 0.001) between both groups.

Conclusions: The Polish version of P-QoL is a valid, reliable, and easily comprehensible instrument to assess quality of life and symptoms in Polish-speaking women suffering from urogenital prolapse.

Key words: pelvic organ prolapse, quality of life, P-QoL, prolapse symptoms, validation study

Ginekologia Polska 2016; 87, 7: 477483

INTRODUCTION

Pelvic organ prolapse (POP) is a common female disorder. The number of the affected women is expected to increase by 45% in the next 30 years as a result of a steadily growing longevity among women aged 50 years and more [1]. POP carries very little morbidity but has a great influence on patient quality of life. Thus, evaluation of the impact of the occurrence and severity of the condition is best-done using disease-specific quality of life tools. The Prolapse Quality of Life questionnaire (P-QoL) is a disease-specific quality of life questionnaire that proved to be a valid and reliable instrument of assessing symptom severity, quality of life, and treatment outcomes in women with POP [2].

In terms of worldwide implementation, the crucial aspect of questionnaires assessing life quality is their applicability in many different settings and countries. This requires their translation into several languages and validation. To date, the P-QoL questionnaire has been validated for Italian-speaking patients and published by Digesu et al., in 2003. Then, it was translated into several languages including English, German, Dutch, Slovakian, Persian, Portuguese, Thai, Japanese, and Turkish [2–9].

OBJECTIVES

The aim of our study was to translate and validate the P-QoL questionnaire into the Polish language.

MATERIAL AND METHODS

The P-QoL questionnaire was translated and validated in several languages [2–9]. The steps of translation and validation were similar in each language. Therefore, we decided to perform the Polish translation and validation in the same manner.

Local Ethics Committee approved of the study. Two independent English-Polish translators, unfamiliar with P-QoL, created the Polish version of the questionnaire. All linguistic and merit-related controversies were resolved with physicians fluent in English (J.R. and K.Z.) and the final version of the Polish questionnaire was accepted. The questionnaire was then back translated into English to prevent any misunderstandings in the Polish version. Both, the original English questionnaire and its Polish equivalent consisted of 38 questions, with 20 questions representing nine quality of life domains (general health perception, prolapse impact, role and physical limitations, social limitations, personal relationships, emotional problems, sleep/energy disturbances and symptoms severity) and 18 questions about prolapse symptoms. The responses ranged from „none/not at all” through „slightly/a little” and „moderately” to „a lot”. A four-point scoring system for each item was used for severity measurement of urogenital prolapse symptoms. The questionnaire does not form the combined score. If a woman has only one domain affected and another woman has all domains affected, both will be considered symptomatic but in different aspects of life quality.

The questionnaire was printed in a large font (16 point) and in a horizontal format in order to improve readability, especially for elderly women.

Study design

Respondents were recruited among consecutive women referred to the urogynecological outpatient clinic at the University Teaching Hospital in Warsaw. An informed consent was obtained from each subject.

The P-QoL questionnaire was distributed among women who agreed to participate in the study. The responses were reviewed and any unanswered questions were completed. Subsequently, all the women were examined in the supine position using the Pelvic Organ Prolapse Quantification System (POP-Q) [10]. Baseline demographic and clinical data were collected.

Statistical analysis

Mann-Whitney U test was used to compare scores between symptomatic and asymptomatic women. Spearman’s correlation was used to evaluate the relationship between P-QoL domain scores and vaginal examination findings in the symptomatic group. Internal consistency was tested using Cronbach’s alpha coefficient. Alpha values of > 0.8 were considered as excellent [11]. All tests were 2-tailed and type-1 error was set at alpha < 0.05. Sample size was calculated for power of 90% and 2:1 allocation of patients.

RESULTS

A total of 260 consecutive women were asked to participate in the study. Fifteen women declined, and 14 women (aged 2430) with asymptomatic prolapse were rejected due to inability to match the groups for age. Thus, a total of 231 women were enrolled. One hundred and fifty-four women (66.7%) presented with complaints of pelvic organ prolapse and 61 (33.6%) had other GYN complaints and were considered asymptomatic for pelvic organ prolapse at the initial work-up. Basic demographics and the grade of uterovaginal prolapse are shown in Table 1. Both groups (symptomatic and asymptomatic) were matched for age. Mean age was 65.6 years (range 3391) for symptomatic and 64.9 years (range 3085) for asymptomatic women (p = 0.8). There were no differences in the weight between the two groups, mean weight was 70.57 kg (range 53115) for symptomatic and 69.86 kg (range 4997) for asymptomatic women (p = 0.7). There was an equal number of vaginal deliveries in both, asymptomatic and symptomatic women (2.6 and 1.9, respectively; p = 0.67).

Table 1. Basic characteristic of symptomatic and asymptomatic women with pelvic organ prolapse

Symptomatic (n = 154)

Asymptomatic (n = 77)

P value

Age (mean, years)

65.6

64,9

0.8

Weight [kg]

70.57

69.86

0.7

Parity (mean)

1.9

2.6

0.6

POP-Q findings

Grade 0

0 (0%)

43 (55.8%)

< 0.001

Grade 1

33 (21.5%)

27 (35.1%)

0.01

Grade 2

47 (30.5%)

4 (5.2%)

< 0.001

Grade 3

64 (41.5%)

3 (3.9%)

<0.001

Grade 4

10 (6.5%)

0 (0%)

<0.001

There was a strong correlation between severity of the disease based on physical findings (POP-Q scale) and the P-QoL scores in main prolapse quality-of-life domains, as shown in Table 2.

Table 2. Comparison of mean quality-of-life domain scores in symptomatic and asymptomatic women (SD values are provided in brackets. U Mann--Whitney test)

Prolapse quality of life domains

Symptomatic

Asymptomatic

P value

General health perception

46.11 (20.33)

19.67 (25.17)

< 0.001

Prolapse impact

74.38 (29.42)

20.55 (32.06)

< 0.001

Role limitations

53.17 (39.04)

9.62 (25.92)

< 0.001

Physical limitations

53.67 (38.92)

10.71 (25.85)

< 0.001

Social limitations

33.92 (34.28)

5.87 (18.41)

< 0.001

Personal relationships

40.69 (46.82)

4.76 (17.06)

< 0.001

Emotions

43.40 (35.01)

6.03 (15.01)

< 0.001

Sleep/Energy

40.12 (31.89)

9.39 (22.84)

< 0.001

Severity measures

41.88 (29.06)

4.88 (10.37)

< 0.001

The total scores for each of the P-QoL domains were found to be significantly higher for symptomatic women as compared to asymptomatic women (p < 0.001), as shown in Table 2.

Women with POP had significantly higher P-QoL scores indicating poorer QoL than those without prolapse. Significant differences were observed for each QoL domain between symptomatic and asymptomatic women (p < 0.001).

The P-QoL questionnaire demonstrated excellent internal consistency with an overall Cronbach alpha of 0.94. In all of the seven quality of life domains the Cronbach alpha values were greater than 0.9, demonstrating excellent internal consistency (Table 3). The internal consistency of the prolapse quality-of-life domains is shown in Table 4.

Table 3. Internal consistency (Cronbach alpha coefficient) for prolapse quality of life domains

Prolapse quality of life domains

Cronbach Alpha

Role limitations

0.949

Physical limitations

0.931

Social limitations

0.930

Personal relationships

0.944

Emotions

0.932

Sleep/Energy

0.933

Severity measures

0.932

Table 4. Correlation between prolapse quality of life domains and vaginal examination findings (POP-Q stage) in symptomatic women

Prolapse quality of life domains

Spearman’s rho coefficient

P value

General health perceptions

0.448

< 0.001

Prolapse impact

0.647

< 0.001

Role limitations

0.578

< 0.001

Physical limitations

0.566

< 0.001

Social limitations

0.506

< 0.001

Personal relationships

0.522

< 0.001

Emotions

0.593

< 0.001

Sleep/Energy

0.564

< 0.001

Severity measures

0.694

< 0.001

DISCUSSION

The issue that determination of the degree of prolapse before and after the treatment alone is insufficient for the assessment of the outcome has been raised by many authors [12–14]. Decisions about the management should also be based on the quality of life of the treated women. Since the prolapse may affect different aspects of a woman’s life, by limiting psychological, physical, social and sexual domains of her life, the severity of these limitations and their impact on the quality of patient life becomes an important source of information for a surgeon while deciding whether a woman needs to be treated or what kind of therapy would be the most appropriate in her case. As it was shown by Digesu et al. [2], who developed the P-QoL questionnaire, and confirmed by many authors who proved its validity [4–6], the questionnaire is a reliable instrument in a routine clinical practice and treatment follow-up. Regardless of many quality-of-life questionnaires for women suffering from urinary incontinence, there is no validated questionnaire to assess QoL of Polish-speaking women with POP. In our study, we demonstrated that the Polish version of the P-QoL questionnaire is a valid and reliable tool. As in other translations, we achieved excellent data consistency with Cronbach’s alpha, greater than 0.9 for each domain. In our opinion, the P-QoL questionnaire currently fills the role of a quality-of-life tool in establishing the degree of severity in subjects with POP. Our results demonstrated that the P-QoL questionnaire is a practical and self-administered instrument to be used in clinical practice and research in order to assess and document the severity and impact of POP in the affected women, thus aiding clinical decisions before treatment commencement.

CONCLUSIONS

Polish version of the P-QOL questionnaire is a validated tool for the assessment of POP in the Polish population. As in the case of the English version, the Polish version of the P-QoL questionnaire has proven to be a useful tool for assessing symptom severity of urogenital prolapse and its impact on the quality of life among the affected women. It is easy to understand and may be administrated and self-completed by the patient. Further multicenter comparison of the usefulness of this instrument would be beneficial for future reference.

REFERENCES

  1. 1. Luber KM, Boero S, Choe JY. The demographics of pelvic floor disorders: current observations and future projections. Am J Obstet Gynecol. 2001, 184: 14961501; discussion 15011503.
  2. 2. Digesu GA, Khullar V, Cardozo L, [et al.]. P-QOL: a validated questionnaire to assess the symptoms and quality of life of women with urogenital prolapse. Int Urogynecol J Pelvic Floor Dysfunct. 2005, 16 (3): 176181; discussion 181.
  3. 3. Digesu GA, Santamato S, Khullar V, [et al.]. Validation of an Italian version of the prolapse quality of life questionnaire. Eur J Obstet Gynecol Reprod Biol. 2003, 106 (2), 184192.
  4. 4. Lenz F, Stammer H, Brocker K, [et al.]. Validation of a German version of the P-QoL Questionnaire. Int Urogynecol J. 2009, 20 (6), 641649.
  5. 5. Svihrova V, Digesu GA, Svihra J, [et al.]. Validation of the Slovakian version of the P-QOL questionnaire. Int Urogynecol J Pelvic Floor Dysfunct. 2010, 21, 5361.
  6. 6. De Oliveira MS, Tamanini JTN, de Aguiar Cavalcanti G. Validation of the Prolapse Quality-of-Life Questionnaire (P-QoL) in Portuguese version in Brazilian women. Int Urogynecol J Pelvic Floor Dysfunct. 2009, 20, 11911202.
  7. 7. Wiwanitkit V. P-QOL questionnaire in Thai version. Int Urogynecol J. 2010, 21 (8), 10391039.
  8. 8. Fukumoto Y, Uesaka Y, Yamamoto K, [et al.]. (Assessment of quality of life in women with pelvic organ prolapse: conditional translation and trial of P-QOL for use in Japan). Nippon Hinyokika Gakkai Zasshi. 2008, 99 (3), 531542.
  9. 9. Claerhout F, Moons P, Ghesquiere S, Verguts J, De Ridder D, Deprest J. Validity, reliability and responsiveness of a Dutch version of the prolapse quality-of-life (P-QoL) questionnaire. Int Urogynecol J. 2010, 21 (5), 569578.
  10. 10. Bump RC, Mattiasson A, Bø K, [et al.]. The standardization of terminology of female pelvic organ prolapse and pelvic floor dysfunction. Am J Obstet Gynecol. 1996, 175 (1), 1017.
  11. 11. Figliola RS, Beasley DE. Theory and design for mechanical measurements. John Wiley & Sons, New York City 1995.
  12. 12. Barber MD, Amundsen CL, Paraiso MFR, Weidner AC, Romero A, Walters MD. Quality of life after surgery for genital prolapse in elderly women: obliterative and reconstructive surgery. Int Urogynecol J Pelvic Floor Dysfunct. 2007, 18 (7), 799806.
  13. 13. Digesu G, Chaliha C, Salvatore S, Hutchings A, Khullar V. The relationship of vaginal prolapse severity to symptoms and quality of life. BJOG. 2005, 112 (7), 971976.
  14. 14. Samuelsson EC, Victor FT, Tibblin G, Svärdsudd KF. Signs of genital prolapse in a Swedish population of women 20 to 59 years of age and possible related factors. Am J Obstet Gynecol. 1999, 180, 299305.

GP_2016_07_Rzepka-5.jpg

GP_2016_07_Rzepka-6.jpg

GP_2016_07_Rzepka-7.jpg

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Group sp. z o.o., ul. Świętokrzyska 73, 80–180 Gdańsk
tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl